NASDAQ · TLRY
Tilray Brands, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for TLRY has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Nov 2026 | $-0.15 | $-0.06 | $-0.21 | 3 |
| Feb 2027 | $-0.14 | $-0.04 | $-0.21 | 3 |
| May 2027 | $0.00 | $0.07 | $-0.08 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · RTTNews · MarketBeat- Zacks · Oct 28, 11:17 AM EDTPost-Q3 Earnings: Is SNDL Stock a Portfolio Must-Have?SNDL's Q3 sales beat expectations, but margin pressure and persistent cannabis weakness cloud its recovery. Can buybacks and U.S. expansion turn the tide?
- The Motley Fool · Oct 27, 9:06 AM EDTDown 70% in 2026, Has Tilray's Stock Finally Bottomed Out?Tilray's low valuation may be enticing to investors as its market cap is just $400 million.
- The Motley Fool · Oct 25, 7:35 AM EDTTilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.Tilray started out as a pure-play marijuana company.
- The Motley Fool · Oct 15, 6:14 PM EDTCanopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution.
- RTTNews · Oct 13, 8:11 AM EDTTilray Medical Gains Approval For In-House Quality Testing At Portugal Facility(RTTNews) – Tilray Brands, Inc. (TLRY) announced that Portugal's National Authority of Medicines and Health Products (INFARMED) has approved the quality control laboratory at its Tilray Medical facility in Cantanhede, Portugal, to conduct microbiological and chemical/physical tes
- The Motley Fool · Oct 12, 2:45 PM EDT3 Huge Red Flags From Tilray's Q1 Earnings ReportTilray's cash burn continues to be a big problem for investors.
- The Motley Fool · Oct 10, 5:38 PM EDTCanopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA.
- The Motley Fool · Oct 10, 2:20 PM EDT3 Reasons I'm Still Not Buying Tilray Stock — Even at Penny-Stock PricesTilray’s financial results have been weak for years.
- MarketBeat · Oct 9, 11:25 AM EDTTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformWhen investors hear talk of U.S. cannabis reform, they often look at major Canadian operators. Tilray Brands (NASDAQ: TLRY) frequently finds itself at the center of this conversation. As rumors of Schedule III reclassification circulate, the market tends to price Tilray Brands b
- Zacks · Oct 9, 8:51 AM EDTCRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.
- The Motley Fool · Oct 8, 10:43 PM EDTTilray (TLRY) Q1 2027 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Oct 8, 12:02 PM EDTTilray Brands Q1 Earnings Call HighlightsCuraleaf’s Higher Aurora Bid Raises the Stakes in Cannabis ConsolidationTilray Brands (NASDAQ:TLRY) reported record first-quarter revenue and gross profit, driven by its BrewDog acquisition, international cannabis growth and pharmaceutical distribution operations, while reaffirmi
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Tilray Brands, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.